Recently, there is a ground-break study about CRISPR–cas9 technology, in which scientists repaired cystic fibrosis trans-membrane conductance regulator (CFTR) locus in those patients having cystic fibrosis by homologous recombination in cultured intestinal stem cells. The gene discussed is CFTR; the disease is cystic fibrosis.